Carlo María Cicala

CM

Statistics

Publications

3

Citations

44

H-Index

3

Active since

2023

Carlo María Cicala is an author at Vall d'Hebron Institute of Oncology specializing in secondary resistance to imatinib, resistance to tyrosine kinase inhibitors, and molecular oncology.

Publications per year

2023–2025

3

Publications

3